Zirconium-catalyzed enantioselective [3+2] cycloaddition of hydrazones to olefins leading to optically active pyrazolidine, pyrazoline, and 1,3-diamine derivatives

Journal of the American Chemical Society

Volumn 126, Issue 36, 2004, Pages 11279-11282

  Yamashita, Yasuhiro ^a   Kobayashi, Shu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MATERIALS; CATALYSIS; OLEFINS; REACTION KINETICS;

CYCLOADDITION; HYDRAZONES; ZIRCONIUM CATALYSTS;

ZIRCONIUM;

1,3 DIAMINE DERIVATIVE; ALKENE DERIVATIVE; DIAMINE; HYDRAZONE DERIVATIVE; MS 153; NEUROPROTECTIVE AGENT; PYRAZOLIDINE DERIVATIVE; PYRAZOLINE DERIVATIVE; UNCLASSIFIED DRUG; ZIRCONIUM;

ARTICLE; CATALYST; CHIRALITY; CYCLOADDITION; DRUG SYNTHESIS; ENANTIOSELECTIVITY; OPTICAL ROTATION; REACTION ANALYSIS;

EID: 4544246197     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja049498l     Document Type: Article

References (37)

1. Reviews: (a) Comprehensive Organic Synthesis; Trost, B. M., Ed.; Pergamon Press: Oxford, 1991; Vol. 5, Chapter 3.
2. (b) Gothelf, K. V.; Jørgensen, K. A. Chem. Rev. 1998, 98, 863.
3. (a) Kanemasa, S.; Kanai, K. J. Am. Chem. Soc. 2000, 122, 10710,
4. (b) Shintani, R.; Fu, G. C. J. Am. Chem. Soc, 2003, 125, 10778.
5. (a) Oyamada, H.; Kobayashi, S. Synlett 1998, 249.
6. (b) Kobayashi, S.; Hasegawa, H.; Ishitani, H. Chem. Lett. 1998, 1131.
7. (c) Kobayashi, S.; Hamada, T.; Manabe, K. J. Am. Chem. Soc. 2002, 124, 5640.
8. (d) Kobayashi, S.; Ogawa, C.; Konishi, H.; Sugiura, M. J. Am. Chem. Soc. 2003, 125, 6610.
9. (e) Hamada, T.; Manabe, K.; Kobayashi, S. J. Am. Chem. Soc. 2004, 126, 7768.
10. See also: (f) Burk, M. J.; Feaster, J. E. J. Am. Chem. Soc. 1992, 114, 6266.
11. Examples of [3+2] cycloaddition of hydrazones with olefins. Under acidic conditions, see: (a) Hesse, K.-D. Liebigs Ann. Chem. 1970, 743, 50.
12. (b) Fevre, G. L.; Sinbandhit, S.; Hamelin, J. Tetrahedron 1979, 35, 1821.
13. (c) Fouchet, B.; Joucla, M.; Hamelin, J. Tetrahedron Lett. 1981, 22, 1333.
14. (d) Shimizu, T.; Hayashi, Y.; Ishikawa, S.; Teramura, K. Bull. Chem. Soc. Jpn. 1982, 55, 2456.
15. (e) Shimizu, T.; Hayashi, Y.; Miki, M.; Teramura, K. J. Org. Chem. 1987, 52, 2277.
16. Under thermal conditions, see: (f) Grigg, R.; Kemp, J.; Thompson, N. Tetrahedron Lett. 1978, 2827.
17. (g) Grigg, R.; Dowling, M.; Jordan, M. W.; Sridharan, V. Tetrahedron 1987, 43, 5873.
18. (h) Snider, B. B.; Conn, R. S. E.; Sealfon, S. J. Org. Chem. 1979, 44, 218.
19. (i) Fevre, G. L.; Hamelin, J. Tetrahedron Lett. 1979, 1757.
20. (J) Ibrahim, Y. A.; Abdou, S. E.; Selim, S. Heterocycles 1982, 19, 819.
21. (k) Badawy, M. A.; El-Bahaie, S. A.; Kadry, A. M.; Ibrahim, Y. A. Heterocycles 1988, 27, 7.
22. (l) Khau, V. V.; Martinelli, M. J. Tetrahedron Lett. 1996, 37, 4323.
23. (m) Sun, B.; Adachi, K.; Noguchi, M. Tetrahedron 1996, 52, 901.
24. Kobayashi, S.; Hirabayashi, R.; Shimizu, H.; Ishitani, H.; Yamashita, Y. Tetrahedron Lett. 2003, 44, 3351.
25. Kobayashi, S.; Shimizu, H.; Yamashita, Y.; Ishitani, H.; Kobayashi, J. J. Am. Chem. Soc. 2002, 124, 13678.
26. The absolute configuration of the cycloadduct 5nc was determined by converting the product to MS-153. The absolute configuration of other adducts was determined by analogy.
27. 4 is rare. See: Biswas, K. M.; Mallik, H.; Halder, S. Monatsh. Chem. 1997, 128, 1283.
28. (a) Sugiura, M.; Kobayashi, S. Org. Lett. 2001, 3, 477.
29. (b) Sugiura, M.; Hagio, H.; Hirabayashi, R.; Kobayashi, S. Synlett 2001, 1225.
30. (c) Sugiura, M.; Hagio, H.; Hirabayashi, R.; Kobayashi, S. J. Am. Chem. Soc. 2001, 123, 12510.
31. (a) Kajiya, S.; Tizuka, H.; Okumura, K.; Fujiwara, J.; Ohto, N.; Kawazura, H.; Takahashi, Y.; Shiga, Y. Eur. Pat. Appl. EP 373512 A1 19900620, 1990.
32. (b) Kosuge, K.; Umemura, K.; Ohashi, K.; Nakashima, M. Jpn. J. Pharmacol. 1995, 67, 277.
33. (c) Umemura, K.; Gemba, T.; Mizuno, A.; Nakashima, M. Stroke 1996, 27, 1624.
34. (d) Kawazura, H.; Takahashi, Y.; Shiga, Y.; Shimada, F.; Ohto, N.; Tamura, A. Jpn. J. Pharmacol. 1997, 73, 317.
35. (e) Shimada, F.; Shiga, Y.; Morikawa, M.; Kawazura, H.; Morikawa, O.; Matsuoka, T.; Nishizaki, T.; Saito, N. Eur. J. Pharmacol 1999, 356, 263.
36. (f) Abekawa, T.; Honda, M.; Ito, K.; Inoue, T.; Koyama, T. Psychopharmacology 2002, 160, 122.
37. We thank Dr. K. Okumura (Mitsui Chemicals) for providing us with copies of the NMR spectrum of MS-153.